1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with deoxycytidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dumitru, CA; Gulbins, E; Weller, M | 1 |
1 other study(ies) available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and deoxycytidine
Article | Year |
---|---|
Ceramide metabolism determines glioma cell resistance to chemotherapy.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Ceramides; Deoxycytidine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gemcitabine; Glioma; Glucosylceramides; Glucosyltransferases; Mice; Mice, Inbred Strains; Mitochondria; Morpholines; RNA, Small Interfering; Sphingolipids; Sphingomyelin Phosphodiesterase; Tumor Stem Cell Assay | 2009 |